Takaya Inagaki
Papers
1
Total Citations
3
H-Index
1
About
Dr. Takaya Inagaki is a leading urologic oncologist whose research focuses on optimizing treatment strategies for high-risk prostate cancer, with a particular emphasis on comparing surgical and radiation-based approaches. His most cited work, a 2024 study, provides critical insights into the trade-offs between robot-assisted radical prostatectomy (RARP) and high-dose-rate brachytherapy combined with external beam radiation and hormone therapy (HDR+). This landmark investigation not only evaluates oncological outcomes but also systematically assesses health-related quality of life (HRQOL), offering patients and clinicians a nuanced understanding of how each modality impacts survival and post-treatment well-being. By directly comparing these advanced interventions, Inagaki’s research addresses a significant gap in evidence-based decision-making for high-risk disease, where treatment choices carry profound implications. His work has already garnered attention within the urologic oncology community, with citations reflecting its relevance to ongoing clinical debates. Inagaki’s contributions are particularly valuable for researchers and clinicians seeking to personalize therapy, balancing aggressive cancer control with preservation of quality of life. His scholarship exemplifies the rigorous comparative effectiveness research needed to guide complex treatment decisions in modern prostate cancer care.
Research Focus
Key Achievements
Top Papers
- 1